Impact of genetic testing for breast-ovarian cancer susceptibility

被引:22
|
作者
Loader, S
Shields, CG
Rowley, PT
机构
[1] Univ Rochester, Sch Med, Div Genet, Dept Med, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med, Dept Family Med, Rochester, NY 14642 USA
来源
GENETIC TESTING | 2004年 / 8卷 / 01期
关键词
D O I
10.1089/109065704323015987
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Previously, we have reported a clinical trial in which any woman in a defined geographic region who had a qualifying family history and who was referred by her physician or who was identified through a regional cancer registry was offered free genetic counseling, BRCA testing, and recommendations based on test results. Each family was represented by one affected and one unaffected person. Of the 87 families actually tested, 13 were found to have deleterious mutations. To assess the impact of the counseling and testing process, we contacted the tested individuals 1 month and 1 year after receiving the test result and those with an abnormal test result after 4 years. Index subjects, we found, differed significantly from relatives. Before coming for counseling, index subjects perceived both their general health and emotional health as worse than did their relatives. After counseling and testing, index subjects continue to worry more about breast cancer than do relatives. Affected subjects, we found, differed significantly from unaffected subjects. Before counseling, affected subjects knew more about breast cancer, perceived their general health as poorer, and reported greater adherence to recommended breast cancer surveillance than did unaffected subjects. After counseling and testing, affected subjects were less satisfied than unaffected subjects with having been tested. This study indicates that the group most prone to distress by cancer risk genetic counseling and testing is not the recruited relatives, nor even those affected with cancer, but rather the index patients themselves. The index patients, i.e., the ones who want the risk information most, appear to undergo the most stress in obtaining it.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [1] Genetic testing for breast-ovarian cancer susceptibility: A regional trial
    Loader, S
    Levenkron, JC
    Rowley, PT
    GENETIC TESTING, 1998, 2 (04): : 305 - 313
  • [2] ATTITUDES ABOUT GENETIC TESTING FOR BREAST-OVARIAN CANCER SUSCEPTIBILITY
    LERMAN, C
    DALY, M
    MASNY, A
    BALSHEM, A
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) : 843 - 850
  • [3] Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility
    Benkendorf, JL
    Reutenauer, JE
    Hughes, CA
    Eads, N
    Willison, J
    Powers, M
    Lerman, C
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 73 (03): : 296 - 303
  • [4] Genetic counseling and testing for breast-ovarian cancer susceptibility: What do women want?
    Audrain, J
    Rimer, B
    Cella, D
    Garber, J
    Peshkin, BN
    Ellis, J
    Schildkraut, J
    Stefanek, M
    Vogel, V
    Lerman, C
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 133 - 138
  • [5] PREDICTED UPTAKE AND IMPACT OF GENETIC TESTING IN INHERITED BREAST-OVARIAN CANCER FAMILIES
    STRUEWING, JP
    LERMAN, CE
    KASE, R
    GIAMBARRESI, T
    TUCKER, MA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 766 - 766
  • [6] Genetic testing and familial implications in breast-ovarian cancer families
    Oosterwijk, Jan C.
    de Vries, Jakob
    Mourits, Marian J.
    de Bock, Geertruida H.
    MATURITAS, 2014, 78 (04) : 252 - 257
  • [7] Genetic counselling: The psychosocial impact in breast-ovarian cancer patients
    Caruso, A
    Contegiacomo, A
    Mariani-Costantini, R
    D'Aversa, C
    Colantuoni, OA
    Corbo, C
    Ottini, L
    Frati, L
    Bianco, AR
    PSYCHO-ONCOLOGY, 1998, 7 (03) : 151 - 151
  • [8] Testing for an inherited susceptibility to breast-ovarian cancer: Consequences one year later.
    Rowley, PT
    Loader, S
    Levenkron, JC
    Shields, CG
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A407 - A407
  • [9] GENETIC-HETEROGENEITY OF BREAST-OVARIAN CANCER REVISITED
    NAROD, S
    FORD, D
    DEVILEE, P
    BARKARDOTTIR, RB
    EYFJORD, J
    LENOIR, G
    SEROVA, O
    EASTON, D
    GOLDGAR, D
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 957 - 958
  • [10] Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing
    De Leeneer, K.
    Van Bockstal, M.
    De Brouwer, S.
    Swietek, N.
    Schietecatte, P.
    Sabbaghian, N.
    Van den Ende, J.
    Willocx, S.
    Storm, K.
    Blaumeiser, B.
    Van Asperen, C. J.
    Wijnen, J. T.
    Leunen, K.
    Legius, E.
    Michils, G.
    Matthijs, G.
    Blok, M. J.
    Gomez-Garcia, E.
    De Paepe, A.
    Tischkowitz, M.
    Poppe, B.
    Claes, K.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (01) : 393 - 398